{
    "2019-04-23": [
        [
            {
                "time": "2019-01-01",
                "original_text": "The best companies for employees in 2019",
                "features": {
                    "keywords": [
                        "best companies",
                        "employees",
                        "2019"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "human resources",
                        "general business"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-15",
                "original_text": "Teva stops testing its migraine drug as cluster headache treatment",
                "features": {
                    "keywords": [
                        "Teva",
                        "migraine drug",
                        "cluster headache",
                        "stops testing"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-14",
                "original_text": "The Daily Biotech Pulse: FDA Accepts Alder's Migraine Drug Application, Gritstone Offering, Lilly's Chinese Sale",
                "features": {
                    "keywords": [
                        "FDA",
                        "Alder",
                        "migraine drug",
                        "Gritstone",
                        "Lilly",
                        "Chinese sale"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "healthcare",
                        "regulatory"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-13",
                "original_text": "Lilly Announces Sale of Legacy Antibiotics Brands and Manufacturing Facility in China",
                "features": {
                    "keywords": [
                        "Lilly",
                        "sale",
                        "antibiotics",
                        "manufacturing facility",
                        "China"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "international business"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}